 Lucas Orth
Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polypharmacy | 3 | 2023 | 84 | 2.250 |
Why?
| | Medication Therapy Management | 2 | 2023 | 72 | 1.500 |
Why?
| | Cholinergic Antagonists | 1 | 2022 | 29 | 0.790 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 53 | 0.770 |
Why?
| | Epilepsies, Myoclonic | 1 | 2022 | 45 | 0.760 |
Why?
| | Pharmaceutical Services | 1 | 2022 | 81 | 0.740 |
Why?
| | Cannabidiol | 1 | 2022 | 108 | 0.690 |
Why?
| | Benzalkonium Compounds | 1 | 2018 | 15 | 0.610 |
Why?
| | Preservatives, Pharmaceutical | 1 | 2018 | 26 | 0.600 |
Why?
| | Albuterol | 1 | 2018 | 105 | 0.590 |
Why?
| | Bronchodilator Agents | 1 | 2018 | 241 | 0.540 |
Why?
| | Delivery of Health Care | 1 | 2022 | 898 | 0.480 |
Why?
| | Child | 7 | 2024 | 20884 | 0.260 |
Why?
| | Child, Preschool | 5 | 2024 | 10490 | 0.250 |
Why?
| | Chronic Disease | 2 | 2022 | 1720 | 0.240 |
Why?
| | Adolescent | 6 | 2024 | 20412 | 0.230 |
Why?
| | Pharmacogenomic Testing | 1 | 2024 | 61 | 0.210 |
Why?
| | Fenfluramine | 1 | 2022 | 14 | 0.200 |
Why?
| | Drug Storage | 1 | 2022 | 57 | 0.190 |
Why?
| | Drug Stability | 1 | 2022 | 159 | 0.190 |
Why?
| | Epileptic Syndromes | 1 | 2022 | 80 | 0.180 |
Why?
| | United States Food and Drug Administration | 1 | 2022 | 205 | 0.180 |
Why?
| | Congenital Hyperinsulinism | 1 | 2021 | 1 | 0.180 |
Why?
| | Diazoxide | 1 | 2021 | 23 | 0.180 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2021 | 36 | 0.170 |
Why?
| | Spasms, Infantile | 1 | 2022 | 122 | 0.170 |
Why?
| | Anticonvulsants | 1 | 2022 | 209 | 0.170 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 171 | 0.170 |
Why?
| | Infant | 3 | 2022 | 8995 | 0.170 |
Why?
| | Medicaid | 1 | 2024 | 431 | 0.160 |
Why?
| | Pharmacists | 1 | 2022 | 246 | 0.160 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 767 | 0.160 |
Why?
| | Temperature | 1 | 2022 | 637 | 0.160 |
Why?
| | Seizures | 1 | 2022 | 401 | 0.160 |
Why?
| | Humans | 10 | 2024 | 129625 | 0.160 |
Why?
| | Status Asthmaticus | 1 | 2018 | 11 | 0.150 |
Why?
| | Nervous System Diseases | 1 | 2021 | 251 | 0.150 |
Why?
| | Nebulizers and Vaporizers | 1 | 2018 | 83 | 0.150 |
Why?
| | Patient-Centered Care | 1 | 2023 | 508 | 0.140 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5075 | 0.140 |
Why?
| | Administration, Inhalation | 1 | 2018 | 667 | 0.130 |
Why?
| | Medication Adherence | 1 | 2021 | 558 | 0.130 |
Why?
| | Retrospective Studies | 3 | 2022 | 14522 | 0.120 |
Why?
| | Infant, Newborn | 2 | 2022 | 5756 | 0.110 |
Why?
| | Quality of Life | 1 | 2023 | 2688 | 0.090 |
Why?
| | United States | 3 | 2024 | 13871 | 0.090 |
Why?
| | Treatment Outcome | 1 | 2018 | 10219 | 0.060 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2024 | 28 | 0.050 |
Why?
| | Male | 4 | 2024 | 63670 | 0.050 |
Why?
| | Fatal Outcome | 1 | 2021 | 300 | 0.040 |
Why?
| | Infant, Premature, Diseases | 1 | 2021 | 93 | 0.040 |
Why?
| | Databases, Factual | 1 | 2024 | 1269 | 0.040 |
Why?
| | Female | 3 | 2021 | 68734 | 0.040 |
Why?
| | Infant, Premature | 1 | 2021 | 542 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2641 | 0.030 |
Why?
| | Risk Factors | 1 | 2021 | 9786 | 0.020 |
Why?
|
|
Orth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|